An Advanced Model to Precisely Estimate the Cell-Free Fetal DNA Concentration in Maternal Plasma.
With the speedy development of sequencing technologies, noninvasive prenatal testing (NIPT) has been widely applied in clinical practice for testing for fetal aneuploidy. The cell-free fetal DNA (cffDNA) concentration in maternal plasma is the most critical parameter for this technology because it a...
Main Authors: | Xiongbin Kang, Jun Xia, Yicong Wang, Huixin Xu, Haojun Jiang, Weiwei Xie, Fang Chen, Peng Zeng, Xuchao Li, Yifan Xie, Hongtai Liu, Guodong Huang, Dayang Chen, Ping Liu, Hui Jiang, Xiuqing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5035032?pdf=render |
Similar Items
-
Noninvasive Prenatal Paternity Testing (NIPAT) through Maternal Plasma DNA Sequencing: A Pilot Study.
by: Haojun Jiang, et al.
Published: (2016-01-01) -
Prediction of human fetal–maternal blood concentration ratio of chemicals
by: Chia-Chi Wang, et al.
Published: (2020-07-01) -
Maternal-Fetal Medicine in China
by: Thomas Q. Zheng, et al.
Published: (2020-01-01) -
Fetal Therapies and Maternal-Fetal Tolerance
Published: (2016) -
Effective noninvasive zygosity determination by maternal plasma target region sequencing.
by: Jing Zheng, et al.
Published: (2013-01-01)